Foundation Leadership

Domenic Sturino Centric CEO

Lindsey Flynt

C12orf65/MTRFR, Mom

Summit Bios

Lindsey is a seasoned medical device professional with extensive experience in surgical technologies and healthcare innovation. As a key contributor to Medtronic’s Advanced Energy division, Lindsey plays a vital role in the distribution of cutting-edge devices such as Aquamantys, PlasmaBlade, and RadiaLux, supporting hospitals across the United States and globally.

With a strong background in orthopaedics, joint replacement, neuro/ortho spine, breast oncology, electrophysiology, and cardiovascular specialties, Lindsey has consistently demonstrated excellence in sales performance and strategic growth. Over the years, she has been recognized as a Plan Maker multiple times, achieving outstanding sales milestones and earning accolades such as President’s Club winner and top national rankings within Medtronic.

Beyond sales achievements, Lindsey has contributed to Medtronic’s internal leadership and development initiatives, serving as a SWOT Member, Field Sales Insight Board Member (2019-2022), and Sales Trainer for Medtronic Transformative Solutions (2011-2013). Additionally, Lindsey has been an active member of Medtronic’s ASPIRE Women’s Network and the ASPIRE Local Area Network Development Committee (FY20 & FY21), supporting leadership and growth opportunities for professionals within the organization.

Outside of the medical device industry, Lindsey is a passionate rare disease advocate dedicated to advancing research for C12orf65/MTRFR-related disorders. Through relentless fundraising efforts, she has successfully raised over $1 million, all of which has been donated to research aimed at finding treatments and cures for this rare disease.

Bringing a wealth of experience in medical device sales, product innovation, and healthcare solutions, as well as a deep commitment to patient advocacy, Lindsey is honored to share insights at the Hereditary Neuropathy Summit, contributing expertise on advancing medical technologies and driving research for rare neurological conditions.